Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 42 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 42 samples: 6 conditions, mostly with about 6 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancerNature communications · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE266956_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1108768 and SRA study SRP506218. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 26 samples.
How we read this: 6 replicated groups read from 42 sample titles; they account for 26 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8257345 LNCaP_sgC_DMSO_IgG
- GSM8257346 LNCaP-sgPRKCI_DMSO_IgG
- GSM8257347 LNCaP-sgC_DMSO_H3K4me3
- GSM8257348 LNCaP-sgPRKCI_DMSO_H3K4me3
- GSM8257349 LNCaP-sgC_DMSO_EZH2
- GSM8257350 LNCaP-sgPRKCI_DMSO_EZH2
- GSM8257351 LNCaP-sgC_DMSO_H3K27me3
- GSM8257352 LNCaP-sgPRKCI_DMSO_H3K27me3
- GSM8257353 LNCaP-sgC_ENZA_IgG LNCaP-sgC_ENZA_IgG
- GSM8257354 LNCaP-sgPRKCI_ENZA_IgG LNCaP-sgPRKCI_ENZA_IgG
- GSM8257355 LNCaP-sgC_ENZA_H3K4me3
- GSM8257356 LNCaP-sgPRKCI_ENZA_H3K4me3
- GSM8257357 LNCaP-sgC_ENZA_EZH2
- GSM8257358 LNCaP-sgPRKCI_ENZA_EZH2
- GSM8257359 LNCaP-sgC_ENZA_H3K27me3
- GSM8257360 LNCaP-sgPRKCI_ENZA_H3K27me3
- GSM8257363 RNSC-7 RNSC
- GSM8257364 RNSC-8 RNSC
- GSM8257365 RNSC-9 RNSC
- GSM8257366 RNSC-10 RNSC
- GSM8257367 RNSC-11 RNSC
- GSM8257368 RNSC-12 RNSC
- GSM8257369 TCD-20 TCD
- GSM8257370 TCD-21 TCD
- GSM8257371 TCD-22 TCD
- GSM8257372 TCD-23 TCD
- GSM8257373 TCD-24 TCD
- GSM8257374 TCD-25 TCD
- GSM8257387 JFL107 JFL
- GSM8257388 JFL108 JFL
- GSM8257389 JFL109 JFL
- GSM8257390 JFL110 JFL
- GSM8257391 JFL111 JFL
- GSM8257392 JFL112 JFL
- GSM8257393 MRC5 MRC
- GSM8257394 MRC6 MRC
- GSM8257395 MRC7 MRC
- GSM8257396 MRC8 MRC
- GSM8403172 LNCaP-sgC_ENZA_IgG LNCaP-sgC_ENZA_IgG
- GSM8403173 LNCaP-sgPRKCI_ENZA_IgG LNCaP-sgPRKCI_ENZA_IgG
+ 2 more — browse all 42 samples with per-sample file links →
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing
- GSE45982 EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation 61 samples shares ezh2
- GSE85390 EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas 38 samples shares ezh2
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.